Healthcare [ 12/13 ] | Drug Manufacturers - Specialty & Generic [ 83/159 ]
NASDAQ | Common Stock
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.
The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions.
Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 8, 24 | 0.00 Increased by +100.00% | -0.23 Increased by +100.00% |
| Mar 11, 24 | -0.21 Increased by +55.32% | -0.24 Increased by +12.50% |
| Nov 9, 23 | -0.34 Increased by +57.50% | -0.29 Decreased by -17.24% |
| Aug 10, 23 | -0.18 Increased by +18.18% | -0.28 Increased by +35.71% |
| May 10, 23 | -0.31 Decreased by -82.35% | -0.30 Decreased by -3.33% |
| Mar 15, 23 | -0.47 Decreased by -327.27% | -0.34 Decreased by -38.24% |
| Nov 9, 22 | -0.80 Decreased by -566.67% | -0.29 Decreased by -175.86% |
| Aug 10, 22 | -0.22 Increased by +51.11% | -0.25 Increased by +12.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 7.87 M Decreased by -0.30% | -10.66 M Increased by +19.84% | Decreased by -135.45% Increased by +19.60% |
| Sep 30, 23 | 8.17 M Decreased by -23.60% | -10.15 M Increased by +54.82% | Decreased by -124.29% Increased by +40.87% |
| Jun 30, 23 | 11.53 M Decreased by -1.39% | -7.15 M Decreased by -15.33% | Decreased by -62.06% Decreased by -16.96% |
| Mar 31, 23 | 9.12 M Decreased by -18.18% | -8.82 M Decreased by -60.40% | Decreased by -96.67% Decreased by -96.02% |
| Dec 31, 22 | 7.89 M Decreased by -21.95% | -13.29 M Decreased by -264.52% | Decreased by -168.47% Decreased by -367.02% |
| Sep 30, 22 | 10.69 M Increased by +13.84% | -22.47 M Decreased by -591.29% | Decreased by -210.19% Decreased by -507.24% |
| Jun 30, 22 | 11.69 M Increased by +40.62% | -6.20 M Decreased by -175.69% | Decreased by -53.06% Decreased by -96.05% |
| Mar 31, 22 | 11.15 M Increased by +22.79% | -5.50 M Decreased by -739.24% | Decreased by -49.31% Decreased by -583.47% |